Direct High-Speed Alphanumeric Printing System for Labware

The U.S. Food and Drug Administration (FDA), specifically the Center for Biologics Evaluation and Research (CBER), is seeking to procure one Direct High-Speed Alphanumeric Printing System for Labware to support labeling requirements for ongoing studies involving tubes and 96-well plates for sample storage. The system must enable high-throughput, direct printing without intermediate sticky labels on containers ranging from 1.5 mL Eppendorf tubes to 50 mL conical tubes, and must withstand extreme temperatures down to -160°C for extended periods while resisting smearing from liquid water and alcohol. Key technical requirements include a benchtop footprint not exceeding 40" x 20" (width x length), operation on standard 100-240 volts AC power, and a one-year ink subscription with comprehensive warranty coverage including on-site preventative maintenance, free parts and labor, and on-site installation and training. The contract will be awarded on a Firm-Fixed-Price basis to the lowest price technically acceptable and responsible offeror. Quotes must be submitted by 1:00 PM Central Time on April 17, 2026, to howard.nesmith@fda.hhs.gov, with all offerors required to be registered and active in SAM.gov and to submit an Accessibility Conformance Report addressing Section 508 ICT accessibility standards.

This is a total small business set-aside under NAICS Code 334118 (Computer Terminal and Other Computer Peripheral Equipment Manufacturing) with an employee size standard of 1,000, making it available exclusively to qualifying small businesses. No prior incumbents or current contractors are identified in the solicitation materials. The contract value is not specified in the available documentation, though all pricing must be presented on a Firm-Fixed-Price basis inclusive of shipping, handling, delivery, installation, and training charges. The procurement is for a single unit of equipment with a one-year warranty and support period beginning upon award. Performance will take place at the FDA/CBER facility located at 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, with the requirement for on-site installation and personnel training at that location.